Last Price$57.32.6%
Market Cap$96.2B
LTM Research & Development Expenses (R&D)
$53.0M
YoY Growth
-75.9%
3Y CAGR
-28.5%
5Y CAGR
-20.6%
Stock quality & Intrinsic value
7/10
55.3% undervalued
Altria Group, Inc. Research & Development Expenses (R&D)
Annual
Quarterly
LTM
Crunching data... Almost there!
| Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Research & Development Expenses (R&D) | $809.0M | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 | $136.0M | $153.0M | $167.0M | $186.0M | $203.0M | $241.0M | $252.0M | $168.0M | $131.0M | $145.0M | $162.0M | $220.0M |
Overvalued or undervalued?
Check the intrinsic value for MO
and see if it's the right time to invest.
Altria Group, Inc. (MO) Research & Development Expenses (R&D) comparison analysis
General
LTM Research & Development Expenses (R&D)
Growth
Company name
YoY growth
3Y CAGR
5Y CAGR
Altria Group, Inc.MO
$53.0M
(75.9%)
(28.5%)
(20.6%)
Median Peer Set
$81.9K
(20.1%)
(6.7%)
0.0%
British American Tobacco p.l.c.BTI
$489.0M
(40.2%)
(13.3%)
3.9%
RLX Technology Inc.RLX
$10.8M
(72.8%)
(40.6%)
53.4%
22nd Century Group, Inc.XXII
$1,189.0K
(83.1%)
(30.9%)
(34.8%)
Turning Point Brands, Inc.TPB
$600.0K
0.0%
(22.7%)
(24.8%)
Ispire Technology Inc.ISPR
$163.8K
(51.8%)
N/A
N/A
Kaival Brands Innovations Group, Inc.KAVL
$0.0
N/A
N/A
N/A
Philip Morris International Inc.PM
$0.0
(100.0%)
(100.0%)
(100.0%)
Universal CorporationUVV
$0.0
N/A
N/A
N/A
Greenlane Holdings, Inc.GNLN
$0.0
N/A
N/A
N/A
Vector Group Ltd.VGR
$0.0
N/A
N/A
N/A
MO key stats
USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
| Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
% growth | 63,963.0 0.0% | 68,920.0 7.7% | 70,324.0 2.0% | 38,051.0 (45.9%) | 15,957.0 (58.1%) | 16,824.0 5.4% | 16,892.0 0.4% | 16,619.0 (1.6%) | 17,500.0 5.3% | 17,663.0 0.9% | 17,945.0 1.6% | 18,854.0 5.1% | 19,337.0 2.6% | 19,494.0 0.8% | 19,627.0 0.7% | 19,796.0 0.9% | 20,841.0 5.3% | 21,111.0 1.3% | 20,688.0 (2.0%) | 20,502.0 (0.9%) |
| Cost of Goods Sold (COGS) | 33,853.0 | 36,764.0 | 37,480.0 | 16,547.0 | 8,270.0 | 7,990.0 | 7,704.0 | 7,680.0 | 7,937.0 | 7,206.0 | 7,785.0 | 7,740.0 | 7,746.0 | 7,543.0 | 7,373.0 | 7,085.0 | 7,818.0 | 7,119.0 | 6,442.0 | 6,218.0 |
% margin | 30,110.0 47.1% | 32,156.0 46.7% | 32,844.0 46.7% | 21,504.0 56.5% | 7,687.0 48.2% | 8,834.0 52.5% | 9,188.0 54.4% | 8,939.0 53.8% | 9,563.0 54.6% | 10,457.0 59.2% | 10,160.0 56.6% | 11,114.0 58.9% | 11,591.0 59.9% | 11,951.0 61.3% | 12,254.0 62.4% | 12,711.0 64.2% | 13,023.0 62.5% | 13,992.0 66.3% | 14,246.0 68.9% | 14,284.0 69.7% |
| Operating Expenses | 14,824.0 | 15,672.0 | 16,036.0 | 8,269.0 | 3,254.0 | 2,951.0 | 2,924.0 | 2,649.0 | 2,249.0 | 2,362.0 | 2,541.0 | 2,749.0 | 2,650.0 | 2,362.0 | 2,756.0 | 2,226.0 | 2,154.0 | 2,432.0 | 2,327.0 | 2,708.0 |
| Research & Development Expenses (R&D) | 809.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 136.0 | 153.0 | 167.0 | 186.0 | 203.0 | 241.0 | 252.0 | 168.0 | 131.0 | 145.0 | 162.0 | 220.0 |
| Selling, General & Administrative Expenses (SG&A) | 12,856.0 | 14,799.0 | 15,077.0 | 7,805.0 | 2,753.0 | 2,931.0 | 2,904.0 | 2,643.0 | 2,281.0 | 2,320.0 | 2,519.0 | 2,687.0 | 2,650.0 | 2,362.0 | 2,718.0 | 2,182.0 | 2,082.0 | 2,360.0 | 2,143.0 | 2,737.0 |
% margin | 15,180.0 23.7% | 16,592.0 24.1% | 17,413.0 24.8% | 13,235.0 34.8% | 4,882.0 30.6% | 5,462.0 32.5% | 6,228.0 36.9% | 6,068.0 36.5% | 7,253.0 41.4% | 8,084.0 45.8% | 7,620.0 42.5% | 8,361.0 44.3% | 8,762.0 45.3% | 9,556.0 49.0% | 9,115.0 46.4% | 20,504.0 103.6% | 10,873.0 52.2% | 11,560.0 54.8% | 8,532.0 41.2% | 11,547.0 56.3% |
| Interest Income | 0.0 | 0.0 | 404.0 | 270.0 | 70.0 | 4.0 | 3.0 | 4.0 | 2.0 | 4.0 | 49.0 | 4.0 | 13.0 | 31.0 | 32.0 | 42.0 | 14.0 | 26.0 | 70.0 | 160.0 |
| Interest Expense | 0.0 | 0.0 | 629.0 | 475.0 | 237.0 | 1,189.0 | 1,136.0 | 1,220.0 | 1,126.0 | 1,049.0 | 808.0 | 817.0 | 760.0 | 736.0 | 665.0 | 1,280.0 | 1,223.0 | 1,188.0 | 1,128.0 | 1,149.0 |
| Pre-tax Income | 14,004.0 | 15,435.0 | 16,536.0 | 13,020.0 | 4,789.0 | 4,877.0 | 5,723.0 | 5,582.0 | 6,477.0 | 6,942.0 | 7,774.0 | 8,078.0 | 21,852.0 | 9,828.0 | 9,341.0 | 766.0 | 6,890.0 | 3,824.0 | 7,389.0 | 10,928.0 |
% effective tax rate | 4,540.0 32.4% | 4,618.0 29.9% | 4,351.0 26.3% | 4,096.0 31.5% | 1,699.0 35.5% | 1,669.0 34.2% | 1,816.0 31.7% | 2,189.0 39.2% | 2,294.0 35.4% | 2,407.0 34.7% | 2,704.0 34.8% | 2,835.0 35.1% | 7,608.0 34.8% | (399.0) (4.1%) | 2,374.0 25.4% | 2,064.0 269.5% | 2,436.0 35.4% | 1,349.0 35.3% | 1,625.0 22.0% | 2,798.0 25.6% |
% margin | 9,416.0 14.7% | 10,435.0 15.1% | 12,022.0 17.1% | 9,786.0 25.7% | 4,930.0 30.9% | 3,206.0 19.1% | 3,905.0 23.1% | 3,390.0 20.4% | 4,180.0 23.9% | 4,535.0 25.7% | 5,070.0 28.3% | 5,241.0 27.8% | 14,239.0 73.6% | 10,222.0 52.4% | 6,963.0 35.5% | (1,298.0) (6.6%) | 4,467.0 21.4% | 2,475.0 11.7% | 5,764.0 27.9% | 8,130.0 39.7% |
| EPS | 4.60 | 5.04 | 5.76 | 4.66 | 2.38 | 1.55 | 1.87 | 1.64 | 2.06 | 2.26 | 2.56 | 2.67 | 7.28 | 5.31 | 3.69 | (0.69) | 2.40 | 1.34 | 3.19 | 4.60 |
| Diluted EPS | 4.56 | 4.99 | 5.71 | 4.62 | 2.36 | 1.54 | 1.87 | 1.64 | 2.06 | 2.26 | 2.56 | 2.67 | 7.28 | 5.31 | 3.69 | (0.69) | 2.40 | 1.34 | 3.19 | 4.57 |
% margin | 17,028.0 26.6% | 18,773.0 27.2% | 18,936.0 26.9% | 14,653.0 38.5% | 5,183.0 32.5% | 6,266.0 37.2% | 7,135.0 42.2% | 6,991.0 42.1% | 7,829.0 44.7% | 8,572.0 48.5% | 8,056.0 44.9% | 8,848.0 46.9% | 9,503.0 49.1% | 10,170.0 52.2% | 10,061.0 51.3% | 11,028.0 55.7% | 11,751.0 56.4% | 12,163.0 57.6% | 12,527.0 60.6% | 12,349.0 60.2% |
Discover more Stock Ideas
Undervalued stocks right now
Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
3M Return 32.1%
S&P Outperformance 19.1%
Next 3M Predicted Return 20.3%
Undervalued growth stocks
Discover the top 20 best undervalued large-cap growth stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
3M Return 35.3%
S&P Outperformance 22.3%
Next 3M Predicted Return 26.8%
Undervalued dividend stocks
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.
3M Return 28.4%
S&P Outperformance 15.4%
Next 3M Predicted Return 16.9%
FAQ
1) What is Altria Group, Inc.'s Research & Development Expenses (R&D)?
As of today, Altria Group, Inc.'s last 12-month Research & Development Expenses (R&D) is $53.0M, based on the financial report for Dec 31, 2024 (Q4’2024).
2) What is Altria Group, Inc.'s Research & Development Expenses (R&D) growth rate?
Over the last year, Altria Group, Inc.'s Research & Development Expenses (R&D) growth was (75.9%). The average annual Research & Development Expenses (R&D) growth rates for Altria Group, Inc. have been (26.0%) over the past three years, (20.6%) over the past five years.
3) Is Altria Group, Inc.'s Research & Development Expenses (R&D) growth rate Good?
Over the last year, Altria Group, Inc.'s Research & Development Expenses (R&D) growth was (75.9%), which is lower than industry growth of (0.7%). It indicates that Altria Group, Inc.'s Research & Development Expenses (R&D) growth is Good.